GSK Jurong is a mixed Global Supply Chain and R&D site. It features clinical and development small molecule manufacturing. Our Tres Cantos site, where medicines have been discovered and developed for over 25 years, is focused on discovering …

R&D is central to our purpose to get ahead of disease together. By combining the science of the immune system with cutting-edge technology, we can discover and develop new medicines and vaccines that will transform people’s lives.

We get ahead of disease together by preventing and treating it with innovation in specialty medicines and vaccines. Our R&D approach combines our scientific focus on the immune system - with the use of advanced technologies.

Advanced technology platforms are central to our R&D approach. We have expertise in AI and functional genomics. Our dedicated global in-house AI team is using machine learning to unlock the potential of complex genetic data with never-before-seen levels of speed, precision and scale.

Feb 12, 2025 · After calling Rockville, Maryland, home for more than eight years, GSK's vaccine and infectious disease R&D teams are planning a move northeast to Cambridge, Massachusetts, the company...

We’re combining the power of genetic and genomic insights into what causes disease, with the speed and scale of artificial intelligence and machine learning (AI/ML) to make better predictions about who a treatment might work for, and why.

Sep 25, 2019 · GSK today announced a $120 million investment to expand its manufacturing facility in Upper Merion, Pennsylvania that will support the delivery of the company’s pipeline, bringing new medicines for cancer and other specialty diseases to patients faster.

Jan 15, 2025 · GSK’s Steven Roberts discusses what his team really looks for in R&D partnerships to create new verticals in vaccine and infectious disease therapeutics.

GSK’s science-led and collaborative approach to vaccine R&D, pairing 2,000 in-house scientists with external expertise, supported more than 250 manuscripts in 2021, and a pipeline of...

Apr 3, 2025 · GSK is growing its R&D (research and development) and manufacturing footprint at its existing Lancaster County operation — building new facilities to manufacture lifesaving vaccines and medications. Currently, one in four Americans are administered a vaccine supplied from the company’s Marietta location, which will increase in size and ...